Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Explore key tips for retirement planning to secure your financial future. Understand what steps to take for a comfortable retirement.
26,014 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Apple filed a federal lawsuit alleging trade secret theft by former employees at OpenAI, threatening hardware know-ho...
Palantir Technologies stock popped today on an earnings-tease event, not a full report. This article explains the dri...
SpaceX stock stumbled since its IPO has sparked questions about what comes next. By charting historical IPO patterns ...
July 2026 brings oil swings and EV demand shifts, narrowing the window for bold bets. A trio—Tesla, Rivian, and NIO—c...
After the latest earnings, investors are weighing growth prospects, margins, and valuation for Domino's. This guide b...
What to watch as J.B. Hunt moves into 2026. This analysis breaks down the Q2 dynamics, segment performance, and what ...
Alta Fox quietly increases its XPEL exposure, lifting the stake to about 15.5% after a roughly $58 million purchase. ...
RE/MAX elevates Chris Lim to president while bringing in two new global sales leaders to drive growth across its affi...
Lemonade's shares swung wildly in a single session, rising on an earnings beat and then tumbling as expectations cool...
A Tuesday pullback in COP shares left investors weighing oil prices, broker notes, and the long-term outlook for ener...
Ethereum faces a tricky moment as analysts flag a bullish flag in a chart that’s inverted, signaling potential big mo...